Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 25,710 shares at $61.81 ($1.6M) on 2024-05-20, disclosed to the SEC on 2024-05-21.
Scheduled sale ($1.6M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.81 | 12,855 | $795K | 50.0% |
| 2 | $61.81 | 12,855 | $795K | 50.0% |
| Total | $61.81 avg | 25,710 | $1.6M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |